Why the study?
Severe hypertriglyceridemia can manifest as eruptive xanthomas, requiring prompt recognition and management to prevent complications such as acute pancreatitis.
Case Report (n=1)
Severe hypertriglyceridemia presenting as eruptive xanthomas can be effectively managed with an insulin infusion and lipid-lowering agents to rapidly reduce triglyceride levels and prevent acute pancreatitis.
May support insulin-based management of severe hypertriglyceridemia with xanthomas; hypothesis-generating and requires prospective validation before practice change.
Hypertriglyceridemia is a common abnormality found in patients in the clinical setting. Severe hypertriglyceridemia may manifest phenotypically as eruptive xanthomas, which are red or yellow papules found on the skin, most commonly on extensor surfaces and buttocks. We present a case of severe hypertriglyceridemia in a patient found in the outpatient setting, which manifested as eruptive xanthomas in his posterior upper arms, back, buttocks, axilla, and legs. Laboratory testing of his lipid profile revealed extremely high triglyceride levels, and the patient was immediately referred to the nearest hospital where he was admitted to the intensive care unit (ICU). He was promptly managed with a low-fat diet, anti-hypertriglyceridemic agents, and insulin infusion, with a dramatic reduction in triglyceride levels. He subsequently underwent a skin biopsy which confirmed the diagnosis of eruptive xanthoma. Rapid reduction in triglyceride levels is instrumental in the prevention of complications, most notably, acute pancreatitis. This article highlights the importance of a high index of suspicion for recognition of the signs and symptoms of severe hypertriglyceridemia, as well as the different management options available for the control of triglyceride levels and the prevention of complications.
No takes yet. Share an insight, caveat, or question.
Munoz et al. (2023) conducted a case report in Severe hypertriglyceridemia and eruptive xanthomas (n=1). Insulin infusion, fenofibrate, and omega-3 acid ethyl esters was evaluated on Serum triglyceride levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: